Deferred Revenue (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Aug. 31, 2016 |
Sep. 30, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
May 31, 2015 |
|
| Deferred Revenue Arrangement [Line Items] | |||||||
| Deferred revenue | $ 1,250,000 | ||||||
| Revenue | $ 742,558 | $ 170,454 | $ 1,535,754 | $ 284,090 | |||
| Cystic Fibrosis Foundation Therapeutics Inc [Member] | |||||||
| Deferred Revenue Arrangement [Line Items] | |||||||
| Amount received upon execution of award agreement | $ 1,000,000 | $ 1,250,000 | $ 1,500,000 | ||||
| X | ||||||||||
- Definition Deferred Revenue Gross No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amount of consideration recognized during the period for the milestone or milestones. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|